Corient Private Wealth’s Insmed INSM Stock Holding History

Corient Private Wealth’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88M	Sell	27,018 -3,231	-11%	-$391K	﹤0.01%	1145
2026 Q1	$4.95M	Buy	30,249 +9,384	+45%	+$1.44M	0.01%	847
2025 Q4	$3.63M	Buy	20,865 +5,305	+34%	+$968K	﹤0.01%	880
2025 Q3	$2.24M	Buy	15,560 +536	+4%	+$65.7K	﹤0.01%	1015
2025 Q2	$1.51M	Buy	15,024 +2,705	+22%	+$207K	﹤0.01%	1170
2025 Q1	$940K	Sell	12,319 -2,411	-16%	-$184K	﹤0.01%	1304
2024 Q4	$1.02M	Buy	14,730 +3,747	+34%	+$270K	﹤0.01%	1315
2024 Q3	$802K	Buy	10,983 +4,223	+62%	+$312K	﹤0.01%	1510
2024 Q2	$453K	Buy	+6,760	New	+$262K	﹤0.01%	1704
2023 Q4	–	Sell	-10,218	Closed	-$258K	–	2297
2023 Q3	$258K	Buy	+10,218	New	+$234K	﹤0.01%	1813

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Corient Private Wealth's INSM Position: Q2 2026 in Review

Corient Private Wealth reduced its Insmed (INSM) stake by 11% in Q2 2026, selling an estimated $391K and leaving 27,018 shares worth $2.88M. The position accounts for ﹤0.01% of the portfolio, ranked #1145.

Corient Private Wealth first reported a position in INSM in Q3 2023 and has held it in 10 quarters since. The position peaked at $4.95M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Corient Private Wealth held 27,018 shares of Insmed worth $2.88M as of Q2 2026.
Corient Private Wealth sold 3,231 Insmed shares in Q2 2026, an estimated $391K.
Insmed made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1145 holding.
Corient Private Wealth first reported a position in Insmed in Q3 2023 and has held it in 10 quarters since.
Corient Private Wealth's Insmed position peaked at $4.95M in Q1 2026.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.